CoreCap Advisors
ABBV icon

CoreCap Advisors’s AbbVie ABBV Stock Holding History

CoreCap Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.73M Buy
21,893
+926
+4% +$237K 0.16% 133
2026
Q2 		$5.28M Sell
20,967
-21,425
-51% -$4.61M 0.16% 151
2026
Q1 		$9.22M Buy
42,392
+24,843
+142% +$5.51M 0.31% 63
2025
Q4 		$4.01M Sell
17,549
-296
-2% -$67.4K 0.14% 149
2025
Q3 		$4.13M Buy
17,845
+798
+5% +$163K 0.15% 137
2025
Q2 		$3.16M Sell
17,047
-36
-0.2% -$6.69K 0.13% 153
2025
Q1 		$3.58M Buy
17,083
+725
+4% +$141K 0.16% 126
2024
Q4 		$2.91M Buy
16,358
+2,254
+16% +$414K 0.13% 149
2024
Q3 		$2.79M Buy
14,104
+752
+6% +$140K 0.13% 162
2024
Q2 		$2.29M Buy
13,352
+134
+1% +$22.2K 0.24% 86
2024
Q1 		$2.41M Buy
13,218
+651
+5% +$112K 0.13% 162
2023
Q4 		$1.95M Buy
12,567
+249
+2% +$36.3K 0.13% 168
2023
Q3 		$1.84M Sell
12,318
-11,786
-49% -$1.73M 0.13% 152
2023
Q2 		$3.25M Buy
+24,104
New +$3.53M 0.23% 86
2022
Q4 		$3.81M Buy
23,591
+2,178
+10% +$334K 0.27% 67
2022
Q3 		$2.87M Buy
21,413
+198
+0.9% +$28.4K 0.24% 75
2022
Q2 		$3.25M Sell
21,215
-855
-4% -$131K 0.25% 69
2022
Q1 		$3.58M Buy
22,070
+1,005
+5% +$146K 0.25% 72
2021
Q4 		$2.85M Buy
+21,065
New +$2.49M 0.19% 96

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

CoreCap Advisors's ABBV Position: Q3 2026 in Review

CoreCap Advisors increased its AbbVie (ABBV) stake by 4.4% in Q3 2026, buying an estimated $237K and bringing the position to 21,893 shares worth $5.73M. The position accounts for 0.16% of the portfolio, ranked #133.

CoreCap Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.22M in Q1 2026. 1,209 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • CoreCap Advisors held 21,893 shares of AbbVie worth $5.73M as of Q3 2026.
  • CoreCap Advisors bought 926 AbbVie shares in Q3 2026, an estimated $237K.
  • AbbVie made up 0.16% of CoreCap Advisors's portfolio in Q3 2026, its #133 holding.
  • CoreCap Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • CoreCap Advisors's AbbVie position peaked at $9.22M in Q1 2026.
  • 1,209 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.